Skip to main content
Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd — Investor Relations & Filings

Ticker · TLSA ISIN · BMG889121031 LEI · 984500769407C5E46F42 US Professional, scientific and technical activities
Open in API
Filings indexed 460 across all filing types
Latest filing 2021-05-21 Director's Dealing
Country BM Bermuda
Listing US TLSA

About Tiziana Life Sciences Ltd

https://www.tizianalifesciences.com/

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company focused on developing innovative immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's core strategy involves utilizing alternative drug delivery routes, such as intranasal administration, to modulate the immune system. Its lead clinical candidate, foralumab (TZLS-401), is the only fully human anti-CD3 monoclonal antibody being investigated for neurological conditions. Foralumab is in clinical development for the treatment of Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS), Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), and Multiple System Atrophy (MSA). The company's pipeline also includes an anti-IL-6 receptor monoclonal antibody (TZLS-501) for potential application in lung diseases.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Director's Dealing Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references an attached Regulatory News Service (RNS) Announcement about PDMR Dealing (person dealing in the company's shares). The document itself is short (2474 characters) and primarily serves to furnish the RNS announcement rather than provide detailed financial data or a full report. It does not contain financial statements, management discussion, or detailed disclosures typical of annual or interim reports. The content is about insider dealing disclosure, which aligns with Director's Dealing filings. Therefore, the appropriate classification is Director's Dealing (DIRS).
2021-05-21 English
ANNUAL REPORT
Annual Report FY 2020
2021-05-17 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 100% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references a Regulatory News Service (RNS) announcement issued in the UK, which is attached as Exhibit 99.1. The document itself is short (2816 characters) and primarily serves to furnish the RNS announcement rather than containing substantive financial data or detailed report content. It explicitly states that the information is being furnished and shall not be deemed "filed" for certain regulatory purposes. This aligns with the characteristics of a Regulatory Filing (RNS) as a general regulatory announcement and compliance document rather than a full report like an Annual Report or Interim Report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-05-07 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 100% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains a regulatory news service announcement about a strategic initiative but does not include detailed financial statements or substantive financial data. The document is relatively short (3125 characters) and primarily serves to furnish an announcement rather than the report itself. According to the rules, such documents that provide announcements or furnish information without detailed financial data should be classified as Regulatory Filings (RNS).
2021-05-05 English
NOTIFICATION OF LATE FILING
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25 Notification of Late Filing submitted to the SEC. It specifically states that the registrant, Tiziana Life Sciences, Plc, is notifying the SEC of a late filing of the Form 20-F annual report for the fiscal year ended December 31, 2020. The document explains the reasons for the delay and commits to filing the report within 15 days after the original due date. This form is a regulatory notification about the delay in filing a report, not the report itself. The document length is 4407 characters, which is relatively short and consistent with a notification form rather than a full annual report. Therefore, this document should be classified as a Regulatory Filing (RNS) because it is a notification related to a regulatory requirement and does not contain the actual annual report or financial data.
2021-04-30 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains a regulatory news service announcement about a participation in a Fireside Chat event. The document is short (2959 characters) and primarily serves to furnish an announcement rather than provide detailed financial data or a full report. It explicitly states that the attached announcement is furnished and not filed as a formal report. There is no substantive financial data or detailed report content. According to the rules, such a document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories and often include announcements and compliance documents.
2021-04-27 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.